MyoKardia Inc Contracts & Agreements

Change in Control and Severance Policy (Filed With SEC on November 5, 2020)

Agreement and Plan of Merger, dated as of October 3, 2020, by and among Bristol-Myers Squibb Company, Gotham Merger Sub Inc. and MyoKardia, Inc (Filed With SEC on October 5, 2020)

Amended and Restated 2015 Employee Stock Purchase Plan (Filed With SEC on August 4, 2020)

Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on August 4, 2020)

Underwriting Agreement, dated May 12, 2020, by and among MyoKardia, Inc. and BofA Securities, Inc., J.P. Morgan Securities LLC, and Credit Suisse Securities (USA) LLC, as... (Filed With SEC on May 14, 2020)

Amended and Restated 2015 Employee Stock Purchase Plan (Filed With SEC on May 6, 2020)

Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on May 6, 2020)

Description of Securities (Filed With SEC on February 27, 2020)

Sales Agreement dated January 3, 2020 by and between MyoKardia, Inc. and Cowen and Company, LLC (Filed With SEC on January 3, 2020)

Termination Agreement, by and between the Registrant and Aventis, Inc. dated July 17, 2019 (Filed With SEC on November 4, 2019)

Transition Agreement, by and between the Registrant and June Lee dated October 4, 2019 (Filed With SEC on November 4, 2019)

Underwriting Agreement, dated March 26, 2019, by and among MyoKardia, Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated, Credit Suisse Securities (USA) LLC, Cowen &... (Filed With SEC on March 28, 2019)

Employment Offer Letter Agreement, by and between the Registrant and William Fairey, dated January 5, 2019 (Filed With SEC on February 28, 2019)

Change in Control and Severance Policy (Filed With SEC on February 28, 2019)

Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on February 28, 2019)

Lease by and between the Registrant and Kashiwa Fudosan America, Inc. dated October 22, 2018 (Filed With SEC on February 28, 2019)

Underwriting Agreement, dated May 22, 2018, by and among MyoKardia, Inc. and J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated, Credit Suisse... (Filed With SEC on May 23, 2018)

Amendment No. 1 to Sublease Agreement by and between REG Life Sciences, LLC (Sublandlord) and MyoKardia, Inc. (Subtenant), dated January 1, 2018 (Filed With SEC on May 8, 2018)

Offer Letter by and between MyoKardia, Inc. and Taylor Harris, dated March 26, 2018 (Filed With SEC on April 4, 2018)

Employment Offer Letter Agreement by and between the Registrant and Marc Semigran, dated October 28, 2016 (Filed With SEC on March 8, 2018)

Employment Offer Letter Agreement by and between the Registrant and Cynthia Ladd, dated December 4, 2017 (Filed With SEC on March 8, 2018)

Sublease Agreement by and between REG Life Sciences, LLC (Sublandlord) and MyoKardia, Inc. (Subtenant), dated October 1, 2017 (Filed With SEC on March 8, 2018)

MYOKARDIA, INC. 3,500,000 Sharesof Common Stock Underwriting Agreement (Filed With SEC on August 9, 2017)

Exhibit C Performance Option Grant Vesting Milestones (Filed With SEC on February 1, 2017)

[ l ]Shares MyoKardia, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on September 26, 2016)

[signature page follows] (Filed With SEC on May 12, 2016)

MYOKARDIA, INC. SENIOREXECUTIVE CASH INCENTIVE BONUS PLAN (Filed With SEC on February 5, 2016)

License and Collaboration Agreement by and between MyoKardia, Inc. and Aventis Inc. (Filed With SEC on October 27, 2015)

[] Shares MyoKardia,Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on October 19, 2015)

Additional abbreviations may also be used though not in the above list. (Filed With SEC on October 19, 2015)

MYOKARDIA, INC. 2015STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on October 19, 2015)

MYOKARDIA, INC. 2015EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on October 19, 2015)

MYOKARDIA, INC. (THE COMPANY) CHANGE IN CONTROL POLICY ADOPTEDON OCTOBER 19, 2015 (Filed With SEC on October 19, 2015)

MYOKARDIA, INC. NON-EMPLOYEEDIRECTOR COMPENSATION POLICY (Filed With SEC on October 19, 2015)

MYOKARDIA, INC. DIRECTOR INDEMNIFICATION AGREEMENT (Filed With SEC on October 13, 2015)

MYOKARDIA, INC. SECONDAMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on September 28, 2015)

AMENDMENT NO. 1 TO SECOND AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on September 28, 2015)

MYOKARDIA, INC. 2012 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:SEPTEMBER 7, 2012 APPROVED BY THE STOCKHOLDERS:SEPTEMBER 7, 2012 TERMINATION DATE: SEPTEMBER 6, 2022... (Filed With SEC on September 28, 2015)

THIRD ROCK VENTURES 455 MISSION BAY BLVD. SOUTH SUITE575 SAN FRANCISCO, CA 94158 (Filed With SEC on September 28, 2015)

MyoKardia, Inc. Employee Confidentiality and Assignment Agreement (Filed With SEC on September 28, 2015)

MYOKARDIA, INC. 400 EAST JAMIE COURT, SUITE 102 SOUTH SAN FRANCISCO, CA 94080 (Filed With SEC on September 28, 2015)

LEASE BRITANNIA MODULAR LABS I HCP LS REDWOOD CITY, LLC, a Delaware limited liability company as Landlord, and MYOKARDIA, INC., aDelaware corporation, as Tenant. Table of Contents (Filed With SEC on September 28, 2015)

License and Collaboration Agreement by and between MyoKardia, Inc. and Aventis Inc. (Filed With SEC on September 28, 2015)